About Us
···Services
- Regulatory Affairs
- Clinical Operations
- Data Management
- Biostatistics
- Medical Services
- Pharmacovigilance
- Quality Assurance
- Biotech Consultancy
- Patient Recruitment
We run studies in all major areas and build tailored teams with the right experience that will ensure the trial’s success.
We have a dedicated team managing trials for numerous indications including cardiovascular and cerebrovascular, rheumatology, musculoskeletal, infectious diseases, diabetes, respiratory and allergy, CNS among others. Developing drugs in internal medicine specialties requires a deep understanding of every aspect for the successful execution. At Pivotal we are confident to offer our clients a consolidated expertise that will expedite all processes within the clinical drug development.
In the past years, Pivotal has conducted 116 trials assessing over 13,015 patients at nearly 1,543 sites.
116 Clinical Trials
1,543 Sites
13,015 Patients
- Cardiology & Cerebrovascular
- Bone, RA & ID
- ID, HIV & Vaccines
- Diabetes
- Allergy & Asthma
- Other IM
We provide our clients with services spanning from Phase I to commercialisation across Europe.
| Phase | #CTs | Sites | Patients |
|---|---|---|---|
| Phase I | 13 | 50 | 255 |
| Phase II | 31 | 279 | 1,217 |
| Phase III | 48 | 844 | 8,937 |
| Phase IV | 24 | 370 | 2,606 |